Bank of New York Mellon Corp - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 188 filers reported holding REGENXBIO INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of REGENXBIO INC
ValueSharesWeighting
Q3 2023$5,937,058
-19.1%
360,696
-1.7%
0.00%
-50.0%
Q2 2023$7,335,490
+9.3%
366,958
+3.4%
0.00%
+100.0%
Q1 2023$6,710,837
-17.6%
354,883
-1.1%
0.00%
-50.0%
Q4 2022$8,141,145
-9.4%
358,957
+5.6%
0.00%0.0%
Q3 2022$8,988,000
+8.5%
340,056
+1.4%
0.00%0.0%
Q2 2022$8,284,000
-27.6%
335,361
-2.7%
0.00%0.0%
Q1 2022$11,440,000
+1.8%
344,671
+0.3%
0.00%0.0%
Q4 2021$11,241,000
-20.9%
343,750
+1.4%
0.00%
-33.3%
Q3 2021$14,206,000
+14.3%
338,873
+5.9%
0.00%
+50.0%
Q2 2021$12,432,000
+4.4%
320,004
-8.3%
0.00%0.0%
Q1 2021$11,910,000
-16.6%
349,133
+10.9%
0.00%
-33.3%
Q4 2020$14,276,000
+60.6%
314,731
-2.5%
0.00%
+50.0%
Q3 2020$8,887,000
-30.7%
322,916
-7.3%
0.00%
-33.3%
Q2 2020$12,829,000
+13.4%
348,359
-0.3%
0.00%
-25.0%
Q1 2020$11,311,000
-21.3%
349,338
-0.4%
0.00%0.0%
Q4 2019$14,365,000
+0.4%
350,616
-12.8%
0.00%0.0%
Q3 2019$14,309,000
-49.4%
401,937
-27.0%
0.00%
-50.0%
Q2 2019$28,265,000
-26.5%
550,225
-18.0%
0.01%
-27.3%
Q1 2019$38,456,000
+72.7%
670,995
+26.4%
0.01%
+57.1%
Q4 2018$22,272,000
-17.9%
530,908
+47.7%
0.01%0.0%
Q3 2018$27,136,000
+18.4%
359,415
+12.6%
0.01%
+16.7%
Q2 2018$22,911,000
+478.3%
319,330
+140.6%
0.01%
+500.0%
Q1 2018$3,962,000
-12.9%
132,735
-3.0%
0.00%0.0%
Q4 2017$4,551,000
-0.3%
136,870
-1.2%
0.00%0.0%
Q3 2017$4,564,000
+30.4%
138,518
-21.9%
0.00%0.0%
Q2 2017$3,501,000
+23.8%
177,277
+21.0%
0.00%0.0%
Q1 2017$2,828,000
-1.1%
146,552
-4.9%
0.00%0.0%
Q4 2016$2,859,000
+263.7%
154,145
+174.8%
0.00%
Q3 2016$786,000
+124.6%
56,091
+28.2%
0.00%
Q2 2016$350,000
+68.3%
43,740
+126.0%
0.00%
Q1 2016$208,000
-31.4%
19,352
+5.9%
0.00%
Q4 2015$303,00018,2750.00%
Other shareholders
REGENXBIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 263,786$7,259,0005.10%
ArchPoint Investors 298,404$8,212,0002.62%
Burrage Capital Management LLC 116,405$3,203,0002.53%
P.A.W. CAPITAL CORP 75,000$2,064,0002.25%
Aquilo Capital Management, LLC 510,760$14,056,0001.49%
WS MANAGEMENT LLLP 436,828$12,022,0001.30%
Redmile Group, LLC 2,228,166$61,319,0001.13%
Ghost Tree Capital, LLC 75,000$2,064,0000.60%
FRAZIER MANAGEMENT LLC 174,200$4,794,0000.43%
Woodline Partners LP 275,442$7,580,0000.25%
View complete list of REGENXBIO INC shareholders